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doi:10.1016/j.hkjn.2011.09.006Summary Tubulointerstitial nephritis and uveitis (TINU) syndrome is characterized by tubu-
lointerstitial nephritis with bilateral sudden-onset anterior uveitis. Currently, only over 200
cases have been described in the literature. TINU syndrome might be underestimated due to
lack of recognition and under-diagnosis. The pathogenesis of TINU syndrome remains unclear.
It has been reported to be associated with infection, drugs or autoimmune diseases. However,
TINU syndrome is mostly postulated to be the result of an autoimmune process. It may involve
both humoral and cellular autoimmunity, with more evidence of the latter since obvious distur-
bances of cell-mediated immunity have been noted in patients with TINU syndrome. Recently,
autoantibodies directed against renal tubular cells have thrown new light on the role of
humoral autoimmunity in TINU syndrome. It is postulated that renal tubular and ciliary body
epithelia might share cross-reactive autoantigens since the major characteristics of TINU
syndrome are the involvement of the kidneys and eyes, and renal tubular and ciliary body
epithelia share some similar functions. This review updates the current understanding on TINU
syndrome, especially its autoimmune nature.
肾小管间质性肾炎-眼色素膜炎 (TINU) 综合征是一种以肾间质损伤和眼色素膜炎为主要表现的的
疾病。迄今，国内外仅有 200 例左右的病例报道。由于对 TINU 综合征的认识尚浅，临床上可能
漏诊了一些病例。目前其发病机制尚不明确。有报道指出 TINU 综合征与感染、药物或自身免疫
疾病有关。其发病机制可能涉及体液免疫及细胞免疫。以往研究认为细胞免疫占据主导地位。近
期研究发现 TINU 综合征患者血清中存在抗肾小管上皮细胞抗体，体液免疫的作用逐渐被认识。
研究认为肾小管间质性肾炎及眼色素膜炎可能存在共同的免疫发病机制，即在肾、眼组织中可能
存在着共同抗原。本文主要就 TINU 综合征的发病机制的一些最新进展，尤其是与自身免疫相关
的部分做一简介。u.cn (M.-H. Zhao).
g Kong Society of Nephrology Ltd. Published by Elsevier Taiwan LLC. All rights reserved.
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Acute interstitial nephritis (AIN) defines a pattern of renal
injury, which is characterized by interstitial inflammatory
infiltrates and edema, and usually associated with an
abrupt deterioration in renal function. AIN has been re-
ported to occur in approximately 1e3% of all renal biopsies
and in 15e27% of patients with acute kidney injury.1e3 In
China, AIN represented 0.8e2.5% of all renal biopsies in
some large series.4e6 In our referral renal diagnostic center
in Peking University First Hospital, AIN accounted for
12.5e17.4% of acute kidney injury.6
The causes of AIN usually fall into one of three
general categories: drug-induced, infection-associated,
and autoimmune-mediated. The latter includes Sjo¨gren’s
syndrome, lupus nephritis and tubulointerstitial nephritis
and uveitis (TINU) syndrome.
TINU syndrome is characterized by tubulointerstitial
nephritis with bilateral sudden-onset anterior uveitis.7 It
was first described by Dobrin et al8 in 1975 and accounts for
5% of patients with AIN.9 TINU syndrome might be under-
estimated due to lack of recognition and under-diagnosis.
Currently, only over 200 cases have been described in the
literature.10 This review updates the current understanding
on TINU syndrome, especially its autoimmune nature.
Epidemiology
The incidence of TINU syndrome is 0.2 cases per million
population per year.11 Most patients with TINU syndrome
are young women, with a median age at onset of 15 years
(range, 9e74 years) and a 3:1 female to male predomi-
nance.10 Recent studies showed that males are now
increasingly diagnosed.12,13 In our renal center, the mean
age of patients with TINU syndrome is 45.2  15.7 years
(range, 16e74 years).14
No definitive identified familial,15 genetic,12 or
geographic clustering has been reported, and only some
sporadic cases have been described. A strong association was
noted with HLA-DQA1*01, HLA-DQB1*05 and HLA-DQB1*01 in
a series of 18 patients.16 Recently, it was reported that HLA-
DRB1*0102 might predispose to TINU syndrome from isolated
interstitial nephritis.17 Several studies found TINU syndrome
in siblings, which perhaps indicates the inheritance of HLA-
linked risk factors of TINU syndrome.18
Pathogenesis
The pathogenesis of TINU syndrome remains unclear,
although it has been reported to be associated with infection
(e.g., herpes zoster virus,10 chlamydia,19 EpsteineBarr
virus20), drugs (e.g., the Chinese herb “Goreisan”,21 nonste-
roidal anti-inflammatory agents and antibiotics10), and
autoimmune diseases (e.g., primary hypoparathyroidism,22
hyperthyroidism,23 rheumatoid arthritis,24 lymphoid inter-
stitial lung disease,25 ankylosing spondylitis,26 IgG4-related
autoimmune disease27).
However, TINU syndrome is mostly postulated to be the
result of anautoimmuneprocess. Itmay involve both humoral
and cellular autoimmunity. In the past, the latter was
strengthened because obvious disturbances in cell-mediatedimmunity were noted in patients with TINU syndrome. For
example, renal interstitial infiltrates are mainly activated
T cells, monocytes/macrophages and mast cells, the infil-
trated T cells are anergic to skin tests with a very low
secretion rate of lymphokines, and patients have general
responsiveness to corticosteroids.28,29 T cells were consid-
ered as playing a major role in the pathogenesis of this
disorder.
Although TINU syndrome is also characterized by hyper-
gammaglobulinemia (IgG), the involvement of humoral
immunity was not postulated to play an important role until
recently. Though some reports indicated an association with
anti-nuclear antibodies,30 rheumatoid factor,8 anti-DNA
antibodies,31 anti-cardiolipin antibodies,32 and cytoplasmic
anti-neutrophil cytoplasmic antibodies (cANCA) in sporadic
cases,33,34 they were considered to be coincidental.10
Ten years ago, Wakaki et al35 found that serum IgG
antibodies from a 13-year-old girl with TINU syndrome were
reactive against 125-kDa human kidney protein, and further
study showed that the IgG antibodies were against cortical
renal tubular cells. Interestingly, the antibodies dis-
appeared as the renal symptoms resolved. They postulated
that the IgG antibodies might contribute to tubular
dysfunction in some patients with TINU syndrome, though
there was no clue for the exact autoantigen and no atten-
tion paid to the eyes. These autoantibodies directed
against renal tubular cells threw new light on the patho-
genesis of TINU syndrome. The major characteristics of
TINU syndrome are the involvement of the kidneys and
eyes. Renal tubular and ciliary body epithelia share some
similar functions, such as those pertaining to electrolyte
transporters sensitive to carbonic anhydrase inhibitors.
Thus, renal tubular and ciliary body epithelia might share
cross-reactive autoantigens.
Shimazaki et al36 reported that serum from a patient
with TINU syndrome could recognize a 125-kDa antigen in
both human kidney and retinal protein extracts. However,
no proteomic identification and subsequent validation were
performed in their study. It is unclear whether the 125-kDa
protein identified in both renal and retinal extracts is the
same protein.
Abed et al37 demonstrated the presence of autoanti-
bodies recognizing a common autoantigen found in both
tubular and uveal cells in the serum of a 15-year-old girl
with TINU syndrome. They performed indirect immunoflu-
orescence techniques with the patient’s serum, incubating
with normal human kidney and normal mouse eye, and
showed IgG deposits in tubular epithelial cells and in uveal
cells, though the direct immunofluorescence study per-
formed on a renal biopsy failed to demonstrate IgG
deposits. Unfortunately, no exact cross-reactive auto-
antigen was identified in their study.
Recently, our group focused on the autoantibodies that
could recognize both kidneys and eyes (Fig. 1). Our previous
study found that autoantibodies against modified C-reactive
protein (mCRP) was associated with tubulointerstitial lesions
in lupus nephritis.38 We further postulated that mCRP might
be one of the target autoantigens in TINU syndrome. To test
the hypothesis, mCRP autoantibodies were detected in
all the nine patients with renal biopsy confirmed TINU
syndrome using direct ELISA. Sera from all nine patients,
collected on the same day of renal biopsy, were confirmed to
Figure 1 Hypothetical role of autoantibodies in TINU syndrome. When there is a breakdown of self-tolerance severe enough to
cause a pathological condition, self-reactive cells might not be eliminated in the thymus and differentiate into pathogenic CD4þT
cells. Autoantigen-driven B-cell clonal selection takes place with the help of cognate CD4þT cells, leading to the production of
autoantibodies, e.g., anti-mCRP autoantibodies. The kidney and the eye may share the same target autoantigen. (A) Indirect
immunofluorescence with anti-human IgG antibodies with focal cytoplasmic staining in renal tubular cells of a renal biopsy section
(100). (B) Indirect immunofluorescence with anti-IgG antibodies with membranous positive staining in human ciliary body cells
and iris (100). Thus, circulating autoantibodies may then be adsorbed to their corresponding tissue-bound antigens in the kidney
and the eye, finally resulting in local complement activation and recruitment of leukocytes. Eventually, local inflammation appears
and results in tubulointerstitial nephritis and uveitis.
48 Y. Tan et al.contain a high titer of autoantibodies against mCRP;
the specificity of autoantibodies against mCRP for TINU
syndrome was demonstrated with various disease controls,
including drug-associated AIN, IgA nephropathy, minimal
change disease, ANCA-associated vasculitis, Sjo¨gren’s
syndrome and systemic amyloidosis. In histopathology study,
mCRP expression was demonstrated in both tubules and
interstitial of human kidney and ocular tissue. Furthermore,
the expression of mCRP was co-localized with human IgG
from patients with TINU syndrome. Our study suggested that
mCRP might be a target autoantigen in TINU syndrome with
the high prevalence of circulating IgG anti-mCRP autoanti-
bodies, the specificity of the autoantibodies, and the co-
localization of mCRP and IgG.14 However, further studies
need to be done to confirm the finding with a larger group of
patients with TINU syndrome. Meanwhile, in vitro and in vivo
studies of the pathologic role of autoantibodies against
mCRP in TINU syndrome should be further investigated.
There are still some uncertainties on the involvement
of humoral autoimmunity in this syndrome. Some reports,including ours, failed to demonstrate IgG deposits in direct
immunofluorescence on a renal biopsy.14,37 Moreover, not
all the autoantibodies might be pathogenic.39 Some were
considered as innocent bystanders.Clinical and pathological characteristics
The clinical features of TINU syndrome are varied.
Systemic symptoms such as fever, weight loss and fatigue
predominate.13
For renal manifestations, sterile pyuria, hematuria, sub-
nephrotic proteinuria and renal insufficiency have been
noted. As for multiple proximal and distal tubular involve-
ment, polyuria, nocturia, aminoaciduria, glucosuria, phos-
phaturia and acidification defects are commonly seen.40
Typical renal biopsy findings include interstitial edema
with plasma cells, lymphocytes and eosinophil infiltration.
Immunofluorescence studies failed to show the presence of
immunoglobulin or complement components in most cases.
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tubules, glomeruli or mesangium, and the presence of
complement components. Non-caseating granulomata were
found in a few of the biopsy specimens.
Ocular symptoms can be found either before (2
months) or after (14 months) renal involvement.10 Most
cases suffered from bilateral non-granulomatous anterior
uveitis with eye redness, pain, blurred vision, and photo-
phobia. The recurrence rate was 41%.10
Diagnosis
The diagnosis of TINU syndrome requires the presence of
both AIN and uveitis and the exclusion of other known
systemic diseases that can cause interstitial nephritis or
uveitis. AIN should be diagnosed histopathologically or
clinically, with onset of bilateral anterior uveitis less than 2
months before or no more than 12 months after AIN.10
Since a number of diseases can affect the kidneys and
eyes simultaneously, the diagnosis of TINU syndrome should
be differentiated from sarcoidosis, Sjo¨gren’s syndrome,
systemic lupus erythematosus, Wegener granulomatosis,
Behc¸et disease, EpsteineBarr virus-associated infectious
mononucleosis, tuberculosis, toxoplasmosis, brucellosis,
syphilis, and histoplasmosis.41
Urinary b2-microglobulin, serum Krebs von den Lunge-6
protein and anti-mCRP autoantibodies are three potential
biomarkers of TINU syndrome. The first two have been
found to be simultaneously decreased in patients with
TINU syndrome after the commencement of treatment and
considered to reflect the renal lesion.42,43 The latter has
been found with elevated titers in both the active phase of
tubulointerstitial nephritis and right before the relapse
of uveitis, which suggests that it might be a potentially
useful biomarker for diagnosis and monitoring of disease
activity.14
Treatment
There are no randomized clinical trials on the treatment of
TINU syndrome. Current clinical practice is based on
empirical medicine and case reports.
For renal involvement, corticosteroids are considered
the mainstay of treatment. Patients with progressive renal
insufficiency are typically treated with prednisone at a dose
of 1 mg/kg per day (usually 40e60 mg/day), which is then
slowly tapered. There are some case reports of a short
course of cyclophosphamide or mycophenolate mofetil
used to reduce recurrence and progressive nephritis, but
without further confirmation.32,44e47
A study of 10 patients indicated that systemic cortico-
steroids may not be required for tubulointerstitial
nephritis, and their renal function recovered within 1 year.
It is mostly considered to be self-limiting and can resolve
spontaneously.48 However, Suzuki et al42 observed that
even delayed prednisolone therapy might result in chronic
renal insufficiency. Moreover, renal scar was observed 2
years after the first renal biopsy in a patient with TINU
syndrome who was treated with prednisolone. Thus, it
was suggested that corticosteroid therapy might not be
sufficient and that immunosuppressive agents might benecessary.45 Prognosis is dependent on the severity of
tubulointerstitial fibrosis.
For uveitis, topical and systemic corticosteroids have
been used. However, recurrences and relapses of uveitis
are frequent. So the ocular disease may require a low-
dose topical treatment regimen for months.13 A study
showed that immunomodulatory agents such as metho-
trexate, azathioprine or cyclosporin A could prevent
relapses.32 Early referral to an ophthalmologist is strongly
recommended.
Conclusion
All in all, TINU syndrome might not be a rare disease. The
pathogenesis may involve the disturbance of both cellular
and humoral immunity. The identification of cross-reactive
autoantigens may substantially add to our understanding of
the disease.
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